Apyx Medical Corporation
Apyx Medical Corporation (APYX) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0000719135 · APYX · NASDAQ · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0000719135 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Apyx Medical Corporation (NASDAQ: APYX) has submitted 971 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0000719135, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Apyx Medical Corporation's most comprehensive regulatory disclosure. The most recent Apyx Medical Corporation 10-K was filed on 2026-03-10 for fiscal year ending 2026. Historical APYX 10-K annual reports are available from 1995 through 2026.
Investors researching Apyx Medical Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
APYX SEC Filings · 8 questionsApyx Medical Corporation (APYX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 971 filings and access original documents at no cost. Apyx Medical Corporation's CIK is 0000719135.